Search Within

Adil Daud

Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
Groups
  1. Department of Medicine (4)
  2. GDMT, Medicine (4)
  3. Gynecologic Medicine Service (4)
  4. Gynecology Disease Management Team (4)
  5. Solid Tumor Oncology Division (4)
  6. Nursing (2)
People
  1. David Spriggs (9)
  2. Carol Aghajanian (4)
  3. Huasong Tian (3)
  4. Nestor Rosales (3)
  5. Xiu Yan (3)
  6. Don Dizon (2)

More People

Years
  1. 2002 (1)
  2. 2001 (6)
  3. 2000 (3)
  4. 1999 (1)
Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (5)
  2. Clinical Cancer Research (2)
  3. Cell Biology International (1)
  4. Current Treatment Options in Oncology (1)
  5. European Journal of Cancer (1)
  6. Women's Oncology Review (1)
Publishers
  1. American Association for Cancer Research (7)
  2. Elsevier Inc. (1)
  3. John Wiley & Sons Ltd. (1)
  4. Springer (1)
  5. Taylor & Francis Group (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies
    Journal Article

    Aghajanian, C.; Soignet, S.; Dizon, D. S.; Pien, C. S.; Adams, J.; Elliott, P. J.; Sabbatini, P.; Miller, V.; Hensley, M. L.; Pezzulli, S.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Effects of the 3'-untranslated region of human TNF-a and the analogues of thalidomide on the expression of luciferase reporter gene in human epithelial carcinoma cell
    Meeting Abstract

    Tian, H.; Daud, A.; Bornmann, W.; Spriggs, D. R.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Induced Akt activation in SKOV-3 cells treated with cisplatin
    Meeting Abstract

    Yan, X. J.; Rosales, N.; Daud, A.; Aghajanian, C.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Phase I study of ZD0473 and liposomal doxorubicin in advanced refractory solid tumor malignancies
    Meeting Abstract

    Dizon, D. S.; Maluf, F.; Aghajanian, C.; Daud, A.; Sabbatini, P.; Soignet, S.; Krug, L.; Pezzulli, S.; Spriggs, D. R.; Beale, P.
    European Journal of Cancer (2001)

    Fulltext@MSK | Save
  • Modulation of cisplatin induced TNF mRNA 3' UTR binding to Elongation Factor 1 α by PKC δ
    Meeting Abstract

    Daud, A.; Spriggs, D.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • [Commentary on] Phase III trial of standard dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small volume stage III ovarian carcinoma: An intergroup study of the Gynecology Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
    Journal Article

    Daud, A.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • New drugs in gynecologic cancer
    Journal Article

    Daud, A.; Munster, P.; Spriggs, D. R.
    Current Treatment Options in Oncology (2001)

    Fulltext@MSK | Save
  • Comprehensive identification of NF-kB activation in SKOV-3WT cells with cisplatin treatment by gene chip hybridization
    Meeting Abstract

    Yan, X. J.; Rosales, N.; Daud, A.; Aghajanian, C.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Effects of analogs of thalidomide on EF1alpha mediated post-transcriptional regulation in human epithelial carcinoma cells by the 3'-untranslated region of tumor necrosis factor-alpha mRNA
    Meeting Abstract

    Tian, H.; Bornmann, W.; Daud, A.; Rosales, N.; Yan, X. J.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Regulation of binding of the tumor necrosis factor (TNFalpha) 3 UTR to elongation factor 1 alpha (EF1 alpha) by PKCdelta
    Meeting Abstract

    Daud, A.; Schwartz, G.; Tian, H.; Yan, X. J.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save